Lars L. Vindeløv

7.7k total citations · 2 hit papers
113 papers, 6.1k citations indexed

About

Lars L. Vindeløv is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Lars L. Vindeløv has authored 113 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 34 papers in Molecular Biology and 29 papers in Oncology. Recurrent topics in Lars L. Vindeløv's work include Hematopoietic Stem Cell Transplantation (39 papers), Cancer Genomics and Diagnostics (23 papers) and Acute Myeloid Leukemia Research (16 papers). Lars L. Vindeløv is often cited by papers focused on Hematopoietic Stem Cell Transplantation (39 papers), Cancer Genomics and Diagnostics (23 papers) and Acute Myeloid Leukemia Research (16 papers). Lars L. Vindeløv collaborates with scholars based in Denmark, France and United Kingdom. Lars L. Vindeløv's co-authors include Ib Jarle Christensen, Nis I. Nissen, Mogens Spang‐Thomsen, Heine H. Hansen, G Jensen, Per Ljungman, Nils Brünner, Stig Lenhoff, Tapani Ruutu and Bengt Sallerfors and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Lars L. Vindeløv

111 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Detergent‐trypsin method for the preparation of nuclei for flow cytometric DNA analysis

1983 1.5k citations Lars L. Vindeløv, Nis I. Nissen et al. profile →
Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei.

1977 441 citations Lars L. Vindeløv profile →

Peers

Countries citing papers authored by Lars L. Vindeløv

Since Specialization

Citations

This map shows the geographic impact of Lars L. Vindeløv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars L. Vindeløv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars L. Vindeløv more than expected).

Fields of papers citing papers by Lars L. Vindeløv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars L. Vindeløv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars L. Vindeløv. The network helps show where Lars L. Vindeløv may publish in the future.

Co-authorship network of co-authors of Lars L. Vindeløv

This figure shows the co-authorship network connecting the top 25 collaborators of Lars L. Vindeløv. A scholar is included among the top collaborators of Lars L. Vindeløv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars L. Vindeløv. Lars L. Vindeløv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome 2016 ·Bone Marrow Transplantation ·Brian Kornblit, (unknown), S J Lee, Stephen R. Spellman, Xiaochun Zhu, Katharina Fleischhauer, Carlheinz Müller, Michael R. Verneris, Klaus Müller, Julia S. Johansen, Lars L. Vindeløv, Peter Garred	3
2	A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation 2014 ·Haematologica ·Brian Kornblit, DG Maloney, Barry E. Storer, Michael B. Maris, Lars L. Vindeløv, Parameswaran Hari, Amelia Langston, Michael A. Pulsipher, Wolfgang Bethge, Thomas R. Chauncey, Thoralf Lange, Finn Bo Petersen, Kai Hübel, Ann E. Woolfrey, Mary E.D. Flowers, R Storb, Brenda M. Sandmaier	28
3	The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT 2012 ·Bone Marrow Transplantation ·Sebastian Giebel, Myriam Labopin, Mohamad Mohty, G J Mufti, Dietger Niederwieser, J.J. Cornelissen, Jeroen J. W. M. Janssen, Nöel Milpied, Lars L. Vindeløv, Eefke Petersen, R Arnold, Andrea Bacigalupo, Didier Blaise, Charles Craddock, A Nagler, Francesco Frassoni, Maria Saduś‐Wojciechowska, Vanderson Rocha	22
4	The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries 2011 ·Bone Marrow Transplantation ·(unknown), Mats Merup, Gunnar Birgegård, (unknown), Lorentz Brinch, Mats Brune, Peter Johansson, Marjut Kauppila, Stig Lenhoff, (unknown), Christer Malm, Kari Remes, Lars L. Vindeløv, Björn Andréasson, (unknown)	43
5	HUMAN LEUKOCYTE ANTIGEN MATCHING AND CONDITIONING IMPACT ON LONG-TERM TRANSPLANT OUTCOME AFTER ALLOGENEIC HSCT FOR CHRONIC LYMPHOCYTIC LEUKEMIA 2010 ·Haematologica ·Mauricette Michallet, Mohamed Sobh, Don Milligan, Stéphane Morisset, (unknown), Vladimír Koza, Tapani Ruutu, NH Russell, Leo F. Verdonck, Nathalie Dhédin, Antonı́n Vı́tek, M. Boogaerts, Lars L. Vindeløv, Jürgen Finke, Valérie Dubois, Anja van Biezen, R. Brand, Peter Dreger	1
6	The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry 2010 ·Leukemia ·Mauricette Michallet, Mohamed Sobh, D Milligan, Stéphane Morisset, Dietger Niederwieser, Vladimír Koza, Tapani Ruutu, NH Russell, Leo F. Verdonck, Nathalie Dhédin, Antonı́n Vı́tek, M. Boogaerts, Lars L. Vindeløv, Jürgen Finke, Valérie Dubois, Anja van Biezen, R. Brand, T. de Witte, Peter Dreger, (unknown)	25
7	Degree of Predicted Minor Histocompatibility Antigen Mismatch Correlates with Poorer Clinical Outcomes in Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation 2010 ·Biology of Blood and Marrow Transplantation ·(unknown), Brian Kornblit, Mette Voldby Larsen, Tania Nicole Masmas, Morten Nielsen, (unknown), Peter Garred, Anette Stryhn, Ole Lund, Søren Buus, Lars L. Vindeløv	12
8	Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioning 2008 ·American Journal of Hematology ·Tania Nicole Masmas, Søren Lykke Petersen, Hans O. Madsen, Lars P. Ryder, Brian Kornblit, Arne Svejgaard, (unknown), Ebbe Dickmeiss, Lars L. Vindeløv	4
9	Allogeneic split-skin grafting in stem cell transplanted patients 2008 ·Journal of Plastic Reconstructive & Aesthetic Surgery ·(unknown), Lars L. Vindeløv, Garbi Schmidt, (unknown)	7
10	Cytokine Gene Expression in Peripheral Blood Mononuclear Cells and Alloreactivity in Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning 2006 ·Biology of Blood and Marrow Transplantation ·Søren Lykke Petersen, Hans O. Madsen, Lars P. Ryder, Arne Svejgaard, Ebbe Dickmeiss, Lars L. Vindeløv	5
11	Haematopoietic stem cell transplantation with non‐myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution 2004 ·British Journal of Haematology ·Søren Lykke Petersen, Hans O. Madsen, Lars P. Ryder, Arne Svejgaard, B. K. Jakobsen, Henrik Sengeløv, Carsten Heilmann, Ebbe Dickmeiss, Lars L. Vindeløv	24
12	Optimisation of the CT.h4S bioassay for detection of human interleukin-4 secreted by mononuclear cells stimulated by phytohaemaglutinin or by human leukocyte antigen mismatched mixed lymphocyte culture 2002 ·Immunology Letters ·Søren Lykke Petersen, Charlotte Russell, Klaus Bendtzen, Lars L. Vindeløv	3
13	Autoreactivity, backstimulation and reproducibility in a helper T lymphocyte precursor assay 2001 ·Journal of Immunological Methods ·Charlotte Russell, Solveig Petersen, Carsten Heilmann, Hans O. Madsen, Lars L. Vindeløv	2
14	Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts 1999 ·Bone Marrow Transplantation ·Kim Theilgaard‐Mönch, Klas Raaschou‐Jensen, Henrik U. Andersen, (unknown), Lars L. Vindeløv, N Jacobsen, Ebbe Dickmeiss	18
15	A comparative study of CD34⁺ cells, CD34⁺ subsets, colony forming cells and cobblestone area forming cells in cord blood and bone marrow allografts 1999 ·European Journal Of Haematology ·Kim Theilgaard‐Mönch, Klas Raaschou‐Jensen, Carsten Heilmann, Helle Andersen, Johannes E. Bock, (unknown), Lars L. Vindeløv, N Jacobsen, Ebbe Dickmeiss	13
16	Outcome of acute lymphoblastic leukaemia in Danish children after allogeneic bone marrow transplantation. Superior survival following transplantation with matched unrelated donor grafts 1998 ·Bone Marrow Transplantation ·(unknown), Carsten Heilmann, Lars L. Vindeløv, N Jacobsen	17
17	Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines 1993 ·British Journal of Cancer ·(unknown), (unknown), Maxwell Sehested, H H Hansen, Lars L. Vindeløv	35
18	In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL) 1989 ·British Journal of Cancer ·(unknown), Lars L. Vindeløv, Henrik Roed, (unknown), Maxwell Sehested, Torben Skovsgaard, H H Hansen	31
19	Dose-Dependent Effect of 17β-Estradiol Determined by Growth Curves and Flow Cytometric DNA Analysis of a Human Breast Carcinoma (T61) Grown in Nude Mice 1985 ·Pathobiology ·Nils Brünner, Mogens Spang‐Thomsen, Lars L. Vindeløv, Susanne Dam Nielsen, Svend A. Engelholm, Birgit Svenstrup	19
20	Clonal Evolution Demonstrated by Flow Cytometric DNA Analysis of a Human Colonic Carcinoma Grown in Nude Mice 1982 ·Pathobiology ·Lars L. Vindeløv, Mogens Spang‐Thomsen, Jakob Visfeldt, (unknown), G Jensen, Nis I. Nissen	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact